Wednesday, Jan 19, 2022 | Last Update : 10:25 PM IST

Alhydroxiquim

Covaxin to use ViroVax's adjuvant Alhydroxiquim-II to boost immune response

Bharat Biotech is currently conducting Phase II human trials of Covaxin after receiving approval from the Drug Controller General of India

05 Oct 2020 2:02 PM

ADVERTISEMENT
ADVERTISEMENT